Overview
Thomas Fynan is a Hematologist Oncology specialist and an Oncologist in Hamden, Connecticut. Dr. Fynan is rated as an Advanced provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Paget Disease of the Breast, Angiosarcoma, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).
His clinical research consists of co-authoring 1 peer reviewed article and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY. Dr. Rai is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome.
Yale University
Scott Huntington is a Hematologist Oncology specialist and an Oncologist in New Haven, Connecticut. Dr. Huntington has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Douglas Gladstone is a Transplant Surgeon in Lake Success, New York. Dr. Gladstone is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Hodgkin Lymphoma, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Anal CancerDr. Fynan isDistinguished. Learn about Anal Cancer.
- AngiosarcomaDr. Fynan isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Fynan isDistinguished. Learn about Breast Cancer.
- Chronic Lymphocytic Leukemia (CLL)Dr. Fynan isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Colorectal CancerDr. Fynan isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Fynan isDistinguished. Learn about Familial Colorectal Cancer.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Autoimmune Hemolytic AnemiaDr. Fynan isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- Breast Cancer in MenDr. Fynan isAdvanced. Learn about Breast Cancer in Men.
- Childhood Iron Deficiency Anemia
- Cholangiocarcinoma (Bile Duct Cancer)
- Chronic B-Cell Leukemia (CBCL)Dr. Fynan isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Experienced
- Acute Eosinophilic PneumoniaDr. Fynan isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Lymphoblastic Leukemia (ALL)Dr. Fynan isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Mountain SicknessDr. Fynan isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Fynan isExperienced. Learn about Acute Myeloid Leukemia (AML).